People · Operator
Named in public records as an officer, director or promoter · active 2008–2008 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Radiorx, Inc. | — | Biotechnology | Series B | $47.7M | $811.6M | 2008 |
Gordon M. Saul at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gordon M. Saul on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Arnold L. Oronsky | 1 | 6 |
| John T. Santini | 1 | 1 |
| Stephen L. Davis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.